| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/05/2015 | WO2015015654A1 Corneal endothelium ecm therapeutic drug |
| 02/05/2015 | WO2015015149A1 Dietary supplement |
| 02/05/2015 | WO2015015013A1 Combinations of a btk inhibitor and fluorouracil for treating cancers |
| 02/05/2015 | WO2015014851A1 Hydroxyalkyl starch for the treatment of hematological neoplasms |
| 02/05/2015 | WO2015014470A1 Compositions for ameliorating and/or preventing adverse side effects in antibiotic therapy |
| 02/05/2015 | US20150038550 Targeting MicroRNAs for Metabolic Disorders |
| 02/05/2015 | US20150038542 Uses of selective inhibitors of hdac8 and treatment of inflammatory conditions |
| 02/05/2015 | US20150038541 Composition and methods for cell modulation |
| 02/05/2015 | US20150038537 Agents For The Control Of Parasites On Animals |
| 02/05/2015 | US20150038519 Organic compounds |
| 02/05/2015 | US20150038511 Treatment of immune-related and inflammatory diseases |
| 02/05/2015 | US20150038510 Cinnoline derivatives |
| 02/05/2015 | US20150038495 Therapeutic agent for pain |
| 02/05/2015 | US20150038494 Thiazolopyrimidine Modulators as Immunosuppressive Agents |
| 02/05/2015 | US20150038480 Compounds that modulate autoimmunity and methods of using the same |
| 02/05/2015 | US20150038468 Estrogen antagonists as treatments for sclerosing disorders |
| 02/05/2015 | US20150038467 Pharmaceutical compositions containing phosphatidylserine and curcumin |
| 02/05/2015 | US20150038464 Methods of increasing light responsiveness in a subject with retinal degeneration |
| 02/05/2015 | US20150038461 Thiopyrimidinecarboxamides as cxcr1/2 modulators |
| 02/05/2015 | US20150038451 Substituted nucleotide analogs |
| 02/05/2015 | US20150038440 Dihydrofuran azetidine derivatives as antiparasitic agents |
| 02/05/2015 | US20150038438 Antibacterial compounds and methods for use |
| 02/05/2015 | US20150038437 Antibacterial compounds and methods for use |
| 02/05/2015 | US20150038432 Compositions and methods for the treatment of retinal degeneration |
| 02/05/2015 | US20150038430 Therapeutic peptidomimetic macrocycles |
| 02/05/2015 | US20150038428 Organogels and emulsions for biological and non-biological applications |
| 02/05/2015 | US20150038417 GLP-1 Agonists |
| 02/05/2015 | US20150038416 Novel glp-1 receptor modulators |
| 02/05/2015 | US20150038407 Oligopeptide compounds and uses thereof |
| 02/05/2015 | US20150038406 Pharmaceutical formulations of tranexamic acid and their use |
| 02/05/2015 | US20150037431 Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities |
| 02/05/2015 | US20150037430 Formulation of a blood composition that is rich in platelet and/or growth factors and contains gelled proteins, and a method for its preparation |
| 02/05/2015 | US20150037426 Modified starch material of biocompatible hemostasis |
| 02/05/2015 | US20150037406 Novel crystalline form of sitagliptin sulfate |
| 02/05/2015 | US20150037391 Local administration of gallium compositions to treat pain |
| 02/05/2015 | US20150037376 Methods and compositions for oral administration of melanocortin receptor agonist compounds |
| 02/05/2015 | US20150037366 Method for treating inflammation |
| 02/05/2015 | US20150037355 Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus |
| 02/05/2015 | US20150037354 Combination therapies including inhibitors of the extracellular domain of e-cadherin |
| 02/05/2015 | US20150037335 Therapeutic use of p75ntr neurotrophin binding protein |
| 02/05/2015 | US20150037333 Tumour necrosis factor receptor fusion proteins and methods of using the same |
| 02/05/2015 | US20150037332 Treatment of metastic breast cancer |
| 02/05/2015 | US20150037325 Slit-robo signaling for diagnosis and treatment of kidney disease |
| 02/05/2015 | US20150037320 Treatment of macrophage-related disorders |
| 02/05/2015 | US20150037318 Treatment of multiple sclerosis with combination of laquinimod and flupirtine |
| 02/05/2015 | US20150037309 Preparation for improving the action of receptors |
| 02/05/2015 | US20150037285 Methods for efficient transfer of viable and bioactive microbiota |
| 02/05/2015 | US20150037282 D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease |
| 02/05/2015 | US20150037281 Variants of prothymosin alpha and methods of using same |
| 02/05/2015 | US20150037280 Substituted pyrazolone compounds and methods of use |
| 02/05/2015 | US20150037263 Treatment of multiple sclerosis with combination of laquinimod and fingolimod |
| 02/05/2015 | US20150037262 Device for the transplantation of cells in suspension |
| 02/05/2015 | US20150034087 Low Dose Pharmaceutical Composition Comprising Zanamivir |
| 02/04/2015 | EP2832855A1 Novel anti-siglec15 antibody |
| 02/04/2015 | EP2832369A1 Compositions for ameliorating and/or preventing adverse side effects in antibiotic therapy |
| 02/04/2015 | EP2832368A1 Fibrosis suppression by inhibiting integrin alpha8beta1 function |
| 02/04/2015 | EP2832367A1 Agent for preventing or treating giant cell tumor or chondrosarcoma arising in bone/soft tissue |
| 02/04/2015 | EP2832349A1 Lactate-based fulvestrant or fulvestrant derivative oily preparation and preparation method thereof |
| 02/04/2015 | EP2830664A1 Administration of a raf inhibitor and a mek inhibitor in the treatment of melanoma |
| 02/04/2015 | EP2830631A1 Administration of eritoran or pharmaceutically acceptable salts thereof to treat orthomyxovirus infections |
| 02/04/2015 | CN104334193A 生长激素释放肽受体反向激动剂或拮抗剂用于治疗睡眠障碍的用途 Ghrelin receptor inverse agonist or antagonist for the treatment of sleep disorders purposes |
| 02/04/2015 | CN104334192A 使用pi3k抑制剂和mek抑制剂治疗癌症的方法 Use pi3k inhibitors and methods of treating cancer mek inhibitors |
| 02/04/2015 | CN104334189A Her2二聚化抑制剂帕妥珠单抗的用途和包含her2二聚化抑制剂帕妥珠单抗的制品 Her2 dimerization inhibitor, pertuzumab use and contains her2 dimerization inhibitor pertuzumab products |
| 02/04/2015 | CN104334176A 用于预防和/或治疗多囊肾病的药物 For the prevention and / or treatment of polycystic kidney disease |
| 02/04/2015 | CN104328130A 柔嫩艾美耳球虫入侵相关蛋白Et CHP559基因及其应用 Eimeria Et CHP559 invasion-associated protein gene and its application |
| 02/04/2015 | CN104324391A Vinexinβ在治疗动脉粥样硬化中的功能和应用 Vinexinβ features and applications in the treatment of atherosclerosis in |
| 02/04/2015 | CN104324390A Mindin基因在治疗动脉粥样硬化中的应用 Mindin gene in the treatment of atherosclerosis in |
| 02/04/2015 | CN104324389A 血液剪切力应答蛋白1在治疗动脉粥样硬化中的功能和应用 Blood shear response protein 1 functions and applications in the treatment of atherosclerosis in |
| 02/04/2015 | CN104324380A 一种纳米药物载体及其制备方法和应用 Nano drug carrier and its preparation method and application |
| 02/04/2015 | CN104324379A α7nAChR激动剂的一种新用途 A new use α7nAChR agonists |
| 02/04/2015 | CN104324378A 用于减少注射引起的皮肤反应的肾上腺素能受体激动剂和填充剂的可注射组合物 Epinephrine for skin reactions caused by the injection of reducing receptor agonist and the filler injectable composition |
| 02/04/2015 | CN104324377A 一种复方降压制剂及其应用 A COMPOUND buck preparation and application |
| 02/04/2015 | CN104324375A 一种用于活体光声成像的核酸纳米结构载体-贵金属光敏造影剂复合物及其制备方法和应用 Nucleic acid nanostructures vectors for in vivo photoacoustic imaging - the precious metals complex sensitive contrast agent and its preparation method and application |
| 02/04/2015 | CN104324014A 一种含醋酸卡泊芬净的药物组合物缓释植入剂及其制备 A caspofungin acetate, pharmaceutical compositions and their preparation comprising sustained release implant |
| 02/04/2015 | CN104323982A 一种含有高弹性模量粘胶纤维的栓剂及其制法 Suppositories their preparation containing high elastic modulus viscose fibers |
| 02/04/2015 | CN103082399B 一种鼻烟及其制备方法 One kind of snuff and its preparation method |
| 02/03/2015 | US8946445 Heterocyclic molecules as apoptosis inducers |
| 02/03/2015 | US8946432 Biaryl derivatives as nAChR modulators |
| 02/03/2015 | US8946304 Methods of treating malnutrition |
| 02/03/2015 | US8946299 Use of calixarenes associated with an antibiotic in the treatment of bacterial infections |
| 02/03/2015 | US8946290 Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 02/03/2015 | US8946279 Fused ring compound for use as mineralocorticoid receptor antagonist |
| 02/03/2015 | US8946275 Treatment of cancer using hypoxia activated prodrugs |
| 02/03/2015 | US8946267 Therapeutic agent or prophylactic agent for neuropathic pain |
| 02/03/2015 | US8946260 17α-hydroxylase/C17,20-lyase inhibitors |
| 02/03/2015 | US8946250 3,4-diarylpyrazoles as protein kinase inhibitors |
| 02/03/2015 | US8946245 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 02/03/2015 | US8946244 2′-fluoro-6′methylene carbocyclic nucleosides and methods of treating viral infections |
| 02/03/2015 | US8946242 Spiro[2.4]heptanes for treatment of flaviviridae infections |
| 02/03/2015 | US8946241 Tyrosine kinase inhibitors |
| 02/03/2015 | US8946238 Pyrazolo[1,5-A]pyrimidines as antiviral agents |
| 02/03/2015 | US8946231 P2X3, receptor antagonists for treatment of pain |
| 02/03/2015 | US8946226 Use of CDK inhibitor for the treatment of glioma |
| 02/03/2015 | US8946219 Combination therapy with a compound acting as a platelet ADP receptor inhibitor |
| 02/03/2015 | US8946216 Indazole derivatives useful as ERK inhibitors |
| 02/03/2015 | US8946215 Hydroxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use |
| 02/03/2015 | US8946213 Alkylated piperazine compounds |
| 02/03/2015 | US8946205 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
| 02/03/2015 | US8946198 Estrogen replacement regimen |
| 02/03/2015 | US8946189 Transplants |